Prostate Carcinoma
Conditions
Keywords
Informed Decision Making, Prostate, Cancer
Brief summary
This clinical trial studies an informed decision making intervention of screening for prostate cancer in predominantly African American participants. It also evaluates participants' knowledge about prostate cancer screening and to improve understanding. Using decision aids such as culturally sensitive written material, verbal information, and videos to educate patients about screening may increase patient participation and knowledge. This may increase confidence in participants' decisions. Raising awareness about prostate cancer in the communities may increase the participants' willingness to be screened for prostate cancer once they have learned about it.
Detailed description
PRIMARY OBJECTIVES: (A) To assess the effectiveness of a proposed educational model for informed decision about Prostate Cancer in high risk men over age 40 which compares informed decision making and shared decision making (B) to improve knowledge about prostate cancer in men over age 18 OUTLINE: Participants complete an educational intervention comprising a 10-20 minute PowerPoint presentation given by an experienced healthcare professional that discusses prostate cancer facts, screening guidelines, risks, benefits, and consequences. Some participants then undergo a screening exam comprising a prostate specific antigen level and digital rectal exam. After completion of study, participants are followed up periodically.
Interventions
OTHEREducational Intervention
Attend 10-20 minute PowerPoint presentation that will discuss prostate cancer facts, screening guidelines, risks, benefits, and consequences
PROCEDUREdigital rectal examination
Undergo digital rectal exam by a licensed healthcare professional. The results of this exam will be subjective as per clinician; however, will be coded as normal or abnormal. This is considered standard of care for prostate cancer screening
OTHERPre-test administration
15 questions which test participants' knowledge of prostate cancer according to ACS guidelines. Questions will be multiple choices and true/false/unsure answers
OTHERSurvey Administration
Survey will be administered at the end of the program for participants to assess their experience
OTHERProstate-specific antigen measurement
PSA levels will be drawn and run as per institutional Laboratory standards. Criteria for referral and follow up will be assessed as per National Comprehensive Cancer Network (NCCN) guidelines
OTHERPost test administration
Post test will include the same 15 questions as on the pretest to assess for improvement in knowledge and understanding
Sponsors
Case Comprehensive Cancer Center
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
19 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Men over the age of 18 will be asked to participate in the educational component of the program; men over the age of 40 will be offered the screening component after the educational portion of the event; participants over age of 40 will have the opportunity to make an informed decision in regards to prostate cancer screening based on this information and the educational material; American Cancer Society (ACS) guidelines recommend having a discussion about screening in men who have an expected mortality of greater than 10 years; data on comorbidities and 10-year mortalities will be collected on every participant using the University of California at San Francisco (UCSF) mortality index * Educational component: men over the age of 18 * Screening component: men over age 40
Exclusion criteria
* Known personal history of prostate cancer * Active malignancy, metastatic disease, or anyone undergoing treatment for malignancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of participants over age 18 that demonstrate improved knowledge about prostate cancer screening | Up to 1 year | Improved understanding will be defined as an increase in the number of correct answers seen on the post Prostate Screening Education Questionnaire. The underlying likelihood of a positive response, or improved understanding of prostate cancer screening, can be estimated using a 95% confidence interval that has a maximum half-width of 6%. |
| Proportion of participants over age 40 who find this education and screening model helpful in making an informed decision about prostate cancer screening as measured by the satisfaction survey questions | Up to 1 year | Helpfulness of the program will be measured on a 5-point Likert scale where the two uppermost categories are considered a positive response. |
Secondary
| Measure | Time frame |
|---|---|
| 10-year expected mortality based on USCF 10-year Mortality Index for all participants | Up to 1 year |
| Proportion of participants with a high 10-year mortality based on UCSF index who choose to be screened for prostate cancer after educational intervention | Up to 1 year |
| Proportion of abnormal results found with screening and referred to follow-up assessed as per National Comprehensive Cancer Network guidelines | Up to 1 year |
| Proportion of participants diagnosed with malignancy based on follow up biopsies and work-up during the course of the study | Up to 1 year |
| Proportion of participants who choose to enter the clinical trial | Up to 1 year |
| Proportion of participants referred to a primary care physician who did not previously have a primary care physician | Up to 1 year |
| Proportion of participants who asked the physician to make a decision for them in spite of educational intervention | Up to 1 year |
| Proportion of participants who expressed satisfied with this proposed informed consent and education model | Up to 1 year |
| Proportion of participants with family history of prostate cancer | Up to 1 year |
| Proportion of participants who choose screening after educational intervention | Up to 1 year |
Countries
United States
Outcome results
None listed